The method, called catch and display for liquid biopsy (CAD-LB), holds promise for diagnosing cancer quickly and affordably, and assessing the progress of therapies used to treat diseases.

About NeoCast™ NeoCast™ is a next-generation, solvent-free, non-adhesive liquid embolic biomaterial designed to preferentially reach distal microvasculature without inducing pain.